424 related articles for article (PubMed ID: 16026086)
1. [Autoantibodies].
Ishihara Y
Rinsho Byori; 2005 Jun; 53(6):562-9. PubMed ID: 16026086
[TBL] [Abstract][Full Text] [Related]
2. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies and their antigens in autoimmune hepatitis.
Bogdanos DP; Mieli-Vergani G; Vergani D
Semin Liver Dis; 2009 Aug; 29(3):241-53. PubMed ID: 19675997
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
6. [Assessment methods of autoantibodies in autoimmune diseases].
Zabek J
Przegl Epidemiol; 2002; 56 Suppl 4():59-66. PubMed ID: 14750264
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
[TBL] [Abstract][Full Text] [Related]
8. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum.
Nifli AP; Notas G; Mamoulaki M; Niniraki M; Ampartzaki V; Theodoropoulos PA; Kopnitsky MJ; Castanas E
J Immunol Methods; 2006 Apr; 311(1-2):189-97. PubMed ID: 16554066
[TBL] [Abstract][Full Text] [Related]
9. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
10. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens.
Almeida González D; Cabrera de León A; Rodríguez Pérez Mdel C; Brito Díaz B; González Hernández A; García García D; Vázquez Moncholi C; Aguirre Jaime A
J Immunol Methods; 2010 Aug; 360(1-2):89-95. PubMed ID: 20600078
[TBL] [Abstract][Full Text] [Related]
11. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
12. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
[TBL] [Abstract][Full Text] [Related]
13. [Detection of anti-nuclear antibodies in liver diseases by indirect immunofluorescence method and enzyme-linked immunosorbent assay].
Koizumi H; Onozuka Y; Shibata M; Sano K; Oosima Y; Miyachi K; Ueno Y
Rinsho Byori; 1999 Aug; 47(8):744-8. PubMed ID: 10511806
[TBL] [Abstract][Full Text] [Related]
14. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders.
Villalta D; Bizzaro N; Da Re M; Tozzoli R; Komorowski L; Tonutti E
Autoimmunity; 2008 Feb; 41(1):105-10. PubMed ID: 18176872
[TBL] [Abstract][Full Text] [Related]
16. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP
J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
[TBL] [Abstract][Full Text] [Related]
17. A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach.
Tedesco A; D'Agostino D; Soriente I; Amato P; Piccoli R; Sabatini P
Autoimmun Rev; 2009 Jan; 8(3):233-7. PubMed ID: 18708166
[TBL] [Abstract][Full Text] [Related]
18. Detection of autoantibodies to nuclear antigens by EIA and IF techniques.
Alem M; Moghadam S; Malki J; Zaidi A; Nayak N; Li TM
Allerg Immunol (Paris); 1997 Sep; 29(7):188, 191-4. PubMed ID: 9373708
[TBL] [Abstract][Full Text] [Related]
19. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.
Grossmann K; Roggenbuck D; Schröder C; Conrad K; Schierack P; Sack U
Cytometry A; 2011 Feb; 79(2):118-25. PubMed ID: 21265005
[TBL] [Abstract][Full Text] [Related]
20. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]